| Teva Pharma AG - Dasatinib-Teva 50 mg, Filmtabletten | | 67100 | | 02 | | Dasatinib-Teva 50 mg | | Filmtabletten | | L01EA02 | | Dasatinib | | 03.05.2019 | | |
| | Composition | | dasatinibum 50 mg ut dasatinibum monohydricum, lactosum monohydricum 65.653 mg, cellulosum microcristallinum, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium max. 0.72 mg, magnesii stearas, Überzug: hypromellosum, triacetinum, E 171, pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Dasatinib | 50 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Dasatinib | 50 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | Hydroxypropylcellulosum | | | | Hypromellosum | | Überzug | | Lactose Monohydrate | 65.653 mg | | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Triacetinum | | |
| |
| |
|
